Formoterol fumarate/Mometasone furoate

富马酸福莫特罗/莫米松糠酸酯

Report date: 2024/06/11 20:00:08

Base Information

Drug NameFormoterol fumarate/Mometasone furoate
Drug Alias Name莫米松糠酸酯/富马酸福莫特罗Mometasone furoate/Formoterol fumarate dihydrate糠酸莫米松+福莫特罗mometasone furoate and formoterol fumarate dihydrateMometasone furoate/Formoterol fumarate +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2010/06/22
Country/TerritoryUnited StatesUnited Kingdom
CombinationsYes Formoterol FumarateMometasone furoate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrganon LLC
Inactive CompaniesSchering-PloughNovartis Pharma AgOrganon & Co
Active IndicationsAsthma
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeR03AK09
Related LinksKEGG